368 related articles for article (PubMed ID: 27715380)
1. Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behçet's Disease.
Bazvand F; Zarei M; Ebrahimiadib N; Karkhaneh R; Davoudi S; Soleimanzadeh M; Sharifian E; Roohipoor R; Modjtahedi BS
Semin Ophthalmol; 2017; 32(6):764-771. PubMed ID: 27715380
[TBL] [Abstract][Full Text] [Related]
2. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.
Ferreira BFA; Rodriguez EEC; Prado LLD; Gonçalves CR; Hirata CE; Yamamoto JH
J Med Case Rep; 2017 Apr; 11(1):104. PubMed ID: 28410605
[TBL] [Abstract][Full Text] [Related]
3. Correlation between Fluorescein Angiographic Findings and Visual Acuity in Behçet Retinal Vasculitis.
Kim M; Kwon HJ; Choi EY; Kim SS; Koh HJ; Lee SC
Yonsei Med J; 2015 Jul; 56(4):1087-96. PubMed ID: 26069134
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of Behçet's disease in the Indian population.
Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
[TBL] [Abstract][Full Text] [Related]
5. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.
Amer R; Alsughayyar W; Almeida D
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946
[TBL] [Abstract][Full Text] [Related]
6. Posterior segment involvement in ocular Behçet's disease.
Ozdal PC; Ortaç S; Taşkintuna I; Firat E
Eur J Ophthalmol; 2002; 12(5):424-31. PubMed ID: 12474927
[TBL] [Abstract][Full Text] [Related]
7. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
[TBL] [Abstract][Full Text] [Related]
8. [Ocular manifestations in Behçet's disease].
Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
[TBL] [Abstract][Full Text] [Related]
9. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.
Khairallah M; Attia S; Yahia SB; Jenzeri S; Ghrissi R; Jelliti B; Zaouali S; Messaoud R
Int Ophthalmol; 2009 Jun; 29(3):135-41. PubMed ID: 18365145
[TBL] [Abstract][Full Text] [Related]
10. Fluorescein angiographic findings and Behcet's disease ocular attack score 24 (BOS24) as prognostic factors for visual outcome in patients with ocular Behcet's disease.
Keorochana N; Homchampa N; Vongkulsiri S; Choontanom R
Int J Retina Vitreous; 2021 Aug; 7(1):48. PubMed ID: 34454608
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
Zlatanović G; Jovanović S; Veselinović D; Zivković M
Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
[TBL] [Abstract][Full Text] [Related]
12. Neovascularization of the optic disc in Behçet's disease.
Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Kir N; Urgancioglu M
Jpn J Ophthalmol; 2006; 50(3):256-65. PubMed ID: 16767382
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features of patients with Behcet's uveitis].
Liu XS; Gao F; Zhao C; Zhang MF
Zhonghua Yan Ke Za Zhi; 2020 Mar; 56(3):217-223. PubMed ID: 32187951
[No Abstract] [Full Text] [Related]
14. Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience.
Sota J; Cantarini L; Vitale A; Sgheri A; Gentileschi S; Caggiano V; Gelardi V; Frediani B; Tosi GM; Fabiani C
Mediators Inflamm; 2020; 2020():6872402. PubMed ID: 32508524
[TBL] [Abstract][Full Text] [Related]
15. Choroidal thickness in Behcet's uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes.
Kim M; Kim H; Kwon HJ; Kim SS; Koh HJ; Lee SC
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6033-9. PubMed ID: 23900605
[TBL] [Abstract][Full Text] [Related]
16. [Ocular manifestations of Behçet's disease].
Saadouli D; Lahmar A; Ben Mansour K; El Afrit N; Yahyaoui S; El Afrit MA
J Fr Ophtalmol; 2021 Feb; 44(2):196-202. PubMed ID: 33380351
[TBL] [Abstract][Full Text] [Related]
17. Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.
Kötter I; Eckstein AK; Stübiger N; Zierhut M
Br J Ophthalmol; 1998 May; 82(5):488-94. PubMed ID: 9713053
[TBL] [Abstract][Full Text] [Related]
18. [Ocular Behçet].
Alami A; Kriet M; Reda K; Laktaoui A; Oubaaz A
Pan Afr Med J; 2017; 26():237. PubMed ID: 28690751
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effect of acetazolamide on cystoid macular oedema in patients with Behcet's disease.
Lashay AR; Rahimi A; Chams H; Davatchi F; Shahram F; Hatmi ZN; Khalkhali H; Beigi B
Eye (Lond); 2003 Aug; 17(6):762-6. PubMed ID: 12928692
[TBL] [Abstract][Full Text] [Related]
20. Fluorescein angiography and visual acuity in active uveitis with Behçet disease.
Yu HG; Kim MJ; Oh FS
Ocul Immunol Inflamm; 2009; 17(1):41-6. PubMed ID: 19294573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
